There are 2934 resources available
Metastatic gastro-oesophageal adenocarcinoma
Presenter: Salah-Eddin Al-Batran
Session: ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal?
Resources:
Slides
Webcast
Metastatic colorectal cancer
Presenter: Michel Ducreux
Session: ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal?
Resources:
Slides
Webcast
Unresectable or relapsed hepato-cellular carcinomas
Presenter: Jean-Luc Raoul
Session: ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal?
Resources:
Slides
Webcast
Are FLT3 Mutated AML a special entity?
Presenter: Gert Ossenkoppele
Session: ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML)
Resources:
Slides
Webcast
3200 - CTONG 1509 : Phase 3 study of bevacizumab with or without erlotinib in untreated Chinese patients with advanced EGFR-mutated NSCLC
Presenter: Qing Zhou
Session: Proffered Paper 2 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
4580 - Outcomes with pembrolizumab (pembro) monotherapy in patients (pts) with PD-L1–positive NSCLC with brain metastases: Pooled analysis of KEYNOTE-001, -010, -024, and -042
Presenter: Aaron Mansfield
Session: Proffered Paper 2 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
1783 - Clinical development of molecular-targeted therapies for non-small cell lung cancer through nationwide genome screening in Japan (LC-SCRUM-Japan)
Presenter: Shingo Miyamoto
Session: Proffered Paper 2 - NSCLC, metastatic
Resources:
Abstract
Slides
4878 - Next-generation sequencing (NGS) in metastatic colorectal cancer (mCRC): novel mutated genes and their effect on response to therapy (Alliance)
Presenter: Federico Innocenti
Session: Proffered Paper 2 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
LBA32 - Encorafenib plus Cetuximab With or Without Binimetinib for BRAF V600E–Mutant Metastatic Colorectal Cancer: Expanded Results from a Randomized, 3-Arm, Phase III Study vs. the Choice of Either Irinotecan or FOLFIRI plus Cetuximab (BEACON CRC)
Presenter: Josep Tabernero
Session: Proffered Paper 2 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
1890 - MIRACLE: Green tea extract versus placebo for the prevention of colorectal adenomas: a randomized, controlled trial
Presenter: Thomas Seufferlein
Session: Proffered Paper 2 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast